These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38720210)

  • 21. A prospective, split-face, randomized study of the efficacy and safety of a novel fractionated intense pulsed light treatment for melasma in Asians.
    Yun WJ; Lee SM; Han JS; Lee SH; Chang SY; Haw S; Lee JB; Won CH; Lee MW; Choi JH; Chang SE
    J Cosmet Laser Ther; 2015; 17(5):259-66. PubMed ID: 25803571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
    Adel S; Serri A; Abd El-Raheem T
    Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Intense Pulse Light Therapy and Tripple Combination Cream Versus Intense Pulse Light Therapy and Tripple Combination Cream Alone in Epidermal Melasma Treatment.
    Shakeeb N; Noor SM; Ullah G; Paracha MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):13-16. PubMed ID: 29290184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
    Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
    Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral tranexamic acid for the treatment of melasma.
    Karn D; Kc S; Amatya A; Razouria EA; Timalsina M
    Kathmandu Univ Med J (KUMJ); 2012; 10(40):40-3. PubMed ID: 23575051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of combination therapy of broadband light and intradermal injection of tranexamic acid in the treatment of chloasma.
    Jia Z; Tian K; Zhong Y; Wang X; Gao S; Xu W; Li K; Wu L
    J Cosmet Dermatol; 2023 May; 22(5):1536-1544. PubMed ID: 36718828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta-analysis.
    Feng X; Su H; Xie J
    J Cosmet Dermatol; 2024 Jan; 23(1):33-43. PubMed ID: 37584240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-session intense pulsed light combined with stable fixed-dose triple combination topical therapy for the treatment of refractory melasma.
    Figueiredo Souza L; Trancoso Souza S
    Dermatol Ther; 2012; 25(5):477-80. PubMed ID: 23046029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
    Basit A; Rahman A; Uddin R
    J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
    Hawwam SA; Ismail M; El-Attar YA
    Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulse in pulse intense pulsed light for melasma treatment: a pilot study.
    Chung JY; Choi M; Lee JH; Cho S; Lee JH
    Dermatol Surg; 2014 Feb; 40(2):162-8. PubMed ID: 24433388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial.
    Yun WJ; Moon HR; Lee MW; Choi JH; Chang SE
    Dermatol Surg; 2014 Aug; 40(8):842-50. PubMed ID: 25022705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulsed dye laser versus intense pulsed light in melasma: a split-face comparative study.
    Hassan AM; Elfar NN; Rizk OM; Eissa NY
    J Dermatolog Treat; 2018 Nov; 29(7):725-732. PubMed ID: 29455565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of fractional QSRL and IPL for melasma treatment in Chinese population.
    Tong LG; Wu Y; Wang B; Xu XG; Tu HD; Chen HD; Li YH
    J Cosmet Laser Ther; 2017 Feb; 19(1):13-17. PubMed ID: 27594596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study.
    Chowdhary B; Mahajan VK; Mehta KS; Chauhan PS; Sharma V; Sharma A; Vashist S; Kumar P
    Arch Dermatol Res; 2021 Mar; 313(2):109-117. PubMed ID: 32356007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intradermal application of tranexamic acid (TA) as treatment of melasma in the out-patients department of a public sector hospital: A pilot study.
    Mehmood M; Ali M; Saleem MA; Asghar S; Hussain MT; Mehmood A
    J Pak Med Assoc; 2022 Nov; 72(11):2275-2277. PubMed ID: 37013301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
    Laothaworn V; Juntongjin P
    J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and possible mechanisms of topical tranexamic acid in melasma.
    Kim SJ; Park JY; Shibata T; Fujiwara R; Kang HY
    Clin Exp Dermatol; 2016 Jul; 41(5):480-5. PubMed ID: 27135282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.